Leading in vitro Discovery efforts to support indication expansion and differentiation for Zasocitinib. Generating data packages for Investigator Brochures, IND filings, branding and congress materials, external advisory boards, and scientific meetings. Coordinating in vitro research efforts to support the development of novel topical medications for autoimmune dermatological indications. Actively contributing to evolving departmental strategy and mentoring of junior staff and direct reports.

Driving Cellular Reprogramming RNA innovation strategy-identifying and engaging key opinion leaders and prioritizing initial areas of focus. Directing project teams with representatives from enabling partner line functions to progress portfolio assets targeting tumor specific vulnerabilities or enhancing anti-tumor immune responses. Preparing in vitro data packages to support IND filings.

Pfizer's Centers for Therapeutic Innovation is a pioneering initiative to transform drug discovery through networked collaborations with academia bridging the best ideas in science with Pfizer’s world class drug development capabilities. I function as a research project lead and immunology project support expert for CTI projects on the east and west coast, participating in academic outreach, proposal and scope of work review and generation, as well as assay development and execution.

Group leader in Cancer Immunopharmacology. Focusing on small molecule assets to modulate the tumor immune micro environment. Partnering with systems biology, academic collaborators, and bioinformatics to identify and prioritize novel onco-immune targets. Investigating the immune modulating potential of CDK portfolio assets.

Indentifying and pre-clinically evaluating novel ADC and immuno-oncology targets.

Researched immune responses in the context of persistent viral infections with a focus on the role of type 1 interferons in modulating immunity. 2013 Boyer-Peter Award recipientRecipient of the Molecular Biology Institute Postdoctoral Scholar Award